Article info
PDFExtended essay
Fair subject selection in clinical research: formal equality of opportunity
- Correspondence to Professor Douglas MacKay, Department of Public Policy, UNC Chapel Hill, 217 Abernethy Hall, 131 S. Columbia St., CB 3435, Chapel Hill, NC 27599, USA; dmackay{at}email.unc.edu
Citation
Fair subject selection in clinical research: formal equality of opportunity
Publication history
- Received December 14, 2015
- Revised May 25, 2016
- Accepted June 22, 2016
- First published July 18, 2016.
Online issue publication
September 23, 2016
Article Versions
- Previous version (23 September 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Fair and equitable subject selection in concurrent COVID-19 clinical trials
- Responsibility in health care: a liberal egalitarian approach
- A Systematic review protocol on workplace equality and inclusion practices in the healthcare sector
- Genetic information, insurance and a pluralistic approach to justice
- Legitimacy in bioethics: challenging the orthodoxy
- Justice and procedure: how does “accountability for reasonableness” result in fair limit-setting decisions?
- Donor-funded research: permissible, not perfect
- Caster semenya and a level playing field
- Is it ethical to keep interim findings of randomised controlled trials confidential?
- Simplified consent in cluster randomised trials: the new EU Clinical Trials Regulation does not provide sufficient guidance